No Data
No Data
No Data
Kringle Pharma: Question and answer session on full-year financial results Earnings Conference year ending September 2024
Allied-Axis, etc. [Stocks with attractive valuations viewed from volume changes]
Stock closing price previous day comparison volume * <6977> Nichi Resistor 950150249800 * <9236> Japan M&A 1116150298300 * <6081> Allied Arc 18121010300 * <4884> Cringler 904124801500 * <4644> Imaginia 10383681900 * <7445> Light On 2065751600 * <4381> B Platts 6222573400
Stocks that moved the previous day part1: Metaplanett, Eltes, Japan Steel, etc.
Stock name <Code> Closing price on the 19th ⇒ Change from the previous day Meta Planet <3350> 2295 +301 Total of 1.7 billion 50 million yen worth of bitcoin was purchased additionally. AI Fusion Capital Group <254A> 1092 +83 announced a share buyback with a limit of 1.4% of total issued shares. Morinaga Confectionery <2201> 2700 +108.5 announced the implementation of a share buyback utilizing ASR. Kringl <4884> 904 +124 applied for permission for "Type 1 pharmaceutical manufacturing and sales".
Kringle Pharma: Full year financial results briefing materials for the fiscal year ending September 2024
Stocks hitting the upper or lower price limit in the afternoon session.
▪︎veru inc <2901> Welsh <3967> Ertes <4051> GMO Financial Gate <4166> Kakkō <4295> Face <4576> De Western Serapitek Research Institute <4884> Kringle Pharma <4935> Liberta <6573> Agile Broadcasting Network <6977> Japan Resistor Manufacturing ▪︎veru inc <9073> Kyojok Transport Trading ※Including temporary upper and lower price limits (indicative value)
Kringle Pharma: Summary of financial results for the fiscal year ending September 2024 [Japanese GAAP] (unconsolidated)
No Data
No Data